This paper is in the following e-collection/theme issue:

Proposals (non-eHealth) (47)

Published on in Vol 8, No 10 (2019): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13696, first published .
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

Authors of this article:

Laura Beaton1 Author Orcid Image ;   Henry F J Tregidgo2 Author Orcid Image ;   Sami A Znati1 Author Orcid Image ;   Sharon Forsyth3 Author Orcid Image ;   Matthew J Clarkson2 Author Orcid Image ;   Steven Bandula4 Author Orcid Image ;   Manil Chouhan4 Author Orcid Image ;   Helen L Lowe5 Author Orcid Image ;   May Zaw Thin6 Author Orcid Image ;   Julian Hague7 Author Orcid Image ;   Dinesh Sharma8 Author Orcid Image ;   Joerg-Matthias Pollok9, 10 Author Orcid Image ;   Brian R Davidson9, 10 Author Orcid Image ;   Jowad Raja7 Author Orcid Image ;   Graham Munneke7 Author Orcid Image ;   Daniel J Stuckey6 Author Orcid Image ;   Zainab A Bascal11 Author Orcid Image ;   Paul E Wilde11 Author Orcid Image ;   Sarah Cooper11 Author Orcid Image ;   Samantha Ryan11 Author Orcid Image ;   Peter Czuczman11 Author Orcid Image ;   Eveline Boucher11 Author Orcid Image ;   John A Hartley1 Author Orcid Image ;   Andrew L Lewis11 Author Orcid Image ;   Marnix Jansen1 Author Orcid Image ;   Tim Meyer1, 12 Author Orcid Image ;   Ricky A Sharma13 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.